Gema Gomez

Gema is a Clinical Trial Manager, working on both the antibody programs for Arrivo. Gema has over 25 years of experience managing Phase I-IV clinical development programs in CNS, GI and infectious diseases. Prior to Arrivo, Gema managed the Clinical Innovation group at UCB and was responsible for finding and implementing new technology to both make clinical trials easier for patients and shorten the time from clinic to study results. Gema was previously the Clinical Development Manager at GSK responsible for leading the early clinical development programs of new epilepsy compounds. Gema’s other job responsibilities have included training, process improvement and SOP development. Gema earned her BA degree in Chemistry from Duke University.